|
2016 Journal Article Long-term outcomes of end-stage kidney disease for patients with lupus nephritisZhang, Lei, Lee, Gavin, Liu, Xusheng, Pascoe, Elaine M., Badve, Sunil V., Boudville, Neil C., Clayton, Philip A., Hawley, Carmel M., Kanellis, John, McDonald, Stephen P., Peh, Chen Au, Polkinghorne, Kevan R. and Johnson, David W. (2016). Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney International, 89 (6), 1337-1345. doi: 10.1016/j.kint.2016.02.014 |
|
2016 Journal Article Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multi-centre registry studyZhang, Lei, Liu, Xusheng, Pascoe, Elaine M., Badve, Sunil V., Boudville, Neil C., Clayton, Philip A., De Zoysa, Janak, Hawley, Carmel M., Kanellis, John, McDonald, Stephen P., Peh, Chen Au, Polkinghorne, Kevan R. and Johnson, David W. (2016). Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: a multi-centre registry study. Nephrology, 21 (5), 387-396. doi: 10.1111/nep.12629 |
|
2016 Journal Article Intensive hemodialysis and mortality risk in Australian and New Zealand populationsMarshall, Mark R., Polkinghorne, Kevan R., Kerr, Peter G., Hawley, Carmel M., Agar, John W. M. and McDonald, Stephen P. (2016). Intensive hemodialysis and mortality risk in Australian and New Zealand populations. American Journal of Kidney Diseases, 67 (4), 617-628. doi: 10.1053/j.ajkd.2015.09.025 |
|
2016 Journal Article Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) studyViecelli, Andrea K., Pascoe, Elaine M., Polkinghorne, Kevan R., Hawley, Carmel M., Paul-Brent, Peta-Anne, Badve, Sunil V., Cass, Alan, Johnson, David W., Kerr, Peter G., Mori, Trevor A., Scaria, Anish, Hooi, Seong L., Ong, Meng L. and Irish, Ashley B. (2016). Baseline characteristics of the omega-3 fatty acids (Fish oils) and aspirin in vascular access OUtcomes in REnal disease (FAVOURED) study. Nephrology, 21 (3), 217-228. doi: 10.1111/nep.12573 |
|
2016 Journal Article Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutionsCho, Yeoungjee, Buchel, Janine, Steppan, Sonja, Passlick-Deetjen, Jutta, Hawley, Carmel M., Dimeski, Goce, Clarke, Margaret and Johnson, David W. (2016). Longitudinal trend in lipid profile of incident peritoneal dialysis patients is not influenced by the use of biocompatible solutions. Peritoneal Dialysis International, 36 (2), 146-153. doi: 10.3747/pdi.2014.00291 |
|
2016 Journal Article Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.Krishnasamy, Rathika, Hawley, Carmel M., Stanton, Tony, Howden, Erin J., Beetham, Kassia, Strand, Haakan, Leano, Rodel L., Haluska, Brian A., Coombes, Jeff S. and Isbel, Nicole M. (2016). Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction.. Nephrology, 21 (2), 108-115. doi: 10.1111/nep.12557 |
|
2016 Journal Article Focus on peritoneal dialysis training: working to decrease peritonitis ratesZhang, Lei, Hawley, Carmel M. and Johnson, David W. (2016). Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrology Dialysis Transplantation, 31 (2), 214-222. doi: 10.1093/ndt/gfu403 |
|
2016 Journal Article The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.Zhang, Lei, Coombes, Jeff, Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, FerrarI, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2016). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trial.. Redox Report, 21 (1), 14-23. doi: 10.1179/1351000215Y.0000000022 |
|
2016 Journal Article Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunctionCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2016). Higher dialysate matrix metalloproteinase-2 levels are associated with peritoneal membrane dysfunction. Peritoneal Dialysis International, 36 (1), 16-25. doi: 10.3747/pdi.2013.00274 |
|
2015 Journal Article The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trialRoberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Perkovic, Vlado, Scaria, Anish, Tonkin, Andrew M., Vergara, Liza A., Hawley, Carmel M., BLOCADE Study Collaborative Group, Reidlinger, Donna, Tan, Ken-Soon and Martin, Andrew (2015). The β-Blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial. American Journal of Kidney Diseases, 67 (6), 902-911. doi: 10.1053/j.ajkd.2015.10.029 |
|
2015 Journal Article The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the honeypot trialZhang, Lei, Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and Johnson, David W. (2015). The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: a sub-study of the honeypot trial. Peritoneal Dialysis International, 35 (7), 712-721. doi: 10.3747/pdi.2014.00206 |
|
2015 Journal Article Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practiceFahim, Magid A., Hayen, Andrew D., Horvath, Andrea R., Dimeski, Goce, Coburn, Amanda, Tan, Ken-Soon, Johnson, David W., Craig, Jonathan C., Campbell, Scott B. and Hawley, Carmel M. (2015). Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: Implications for clinical practice. Clinical Chemistry and Laboratory Medicine, 54 (5), e149-e150. doi: 10.1515/cclm-2015-0998 |
|
2015 Journal Article Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohortMallett, A., Hughes, P., Szer, J., Tuckfield, A., Van Eps, C., Cambell, S. B., Hawley, C., Burke, J., Kausman, J., Hewitt, I., Parnham, A., Ford, S. and Isbel, N. (2015). Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Internal Medicine Journal, 45 (10), 1054-1065. doi: 10.1111/imj.12864 |
|
2015 Journal Article Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2015). Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients. Nephrology Dialysis Transplantation, 30 (10), 1774-1779. doi: 10.1093/ndt/gfv260 |
|
2015 Journal Article Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis PopulationMarshall, Mark R., Polkinghorne, Kevan R., Kerr, Peter G., Agar, John W.M., Hawley, Carmel M. and McDonald, Stephen P. (2015). Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. American Journal of Kidney Diseases, 66 (3), 489-498. doi: 10.1053/j.ajkd.2015.03.014 |
|
2015 Journal Article The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney diseaseLee, Gavin, Krishnasamy, Rathika, Hawley, Carmel M. and Johnson, David W. (2015). The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease. Expert Review of Endocrinology and Metabolism, 10 (6), 565-568. doi: 10.1586/17446651.2015.1079124 |
|
2015 Journal Article Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysisTong, Allison, Manns, Braden, Hemmelgarn, Brenda, Wheeler, David C., Tugwell, Peter, Winkelmayer, Wolfgang C., van Biesen, Wim, Crowe, Sally, Kerr, Peter G., Polkinghorne, Kevan R., Howard, Kirsten, Pollock, Carol, Hawley, Carmel M., Johnson, David W., McDonald, Stephen P., Gallagher, Martin P., Urquhart-Secord, Rachel and Craig, Jonathan C. (2015). Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis. Trials, 16 (364) 364, 464-475. doi: 10.1186/s13063-015-0895-7 |
|
2015 Journal Article Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialBadve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015). Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 (33) 33, 1-10. doi: 10.1186/s40697-015-0066-5 |
|
2015 Journal Article An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry)Nadeau-Fredette, Annie-Claire, Hawley, Carmel M., Pascoe, Elaine M., Chan, Christopher T., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry). Clinical Journal of the American Society of Nephrology, 10 (8), 1397-1407. doi: 10.2215/CJN.00840115 |
|
2015 Journal Article Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseLo, Clement, Toyama, Tadashi, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel, Pilmore, Helen, Badve, Sunil V., Perkovic, Vlado and Zoungas, Sophia (2015). Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews, 2015 (8) CD011798. doi: 10.1002/14651858.CD011798 |
